Merck, known as MSD outside of the United States and Canada, will hold its first-quarter 2023 sales and earnings conference call with institutional investors and analysts at 9:00 a.m. ET on Thursday, April 27.
Merck to Hold First-Quarter 2023 Sales and Earnings Conference Call on April 27 Read More »
DXVX announces that its affiliated company Oxford Vacmedix has completed Phase 1a trial of cancer vaccine and plans to proceed Phase 1b trial of OVM-200.
On March 29, 2023, Zylox-Tonbridge Medical Technology Co., Ltd. released its annual financial results for 2022.
Hansa Biopharma AB “Hansa”, a pioneer in enzyme technology for rare immunological conditions, announced the release of the Annual Report 2022.
Bioretec Ltd, a pioneer in bioresorbable orthopedic implants, has announced receiving the market authorization of the U.S. Food and Drug Administration for its pioneering RemeOs™ trauma screw to be used for healing of bone fractures aligned with the clinical trial.
AlzeCure Pharma AB, a pharmaceutical company that develops a broad portfolio of small molecule candidate drugs for diseases affecting the central nervous system, with projects in both Alzheimer’s disease and pain, announced that the company’s presentation at the Alzheimer’s conference AD/PD 2023 is now available in its entirety on the company’s website.
Comanche Biopharma Corp., a biopharmaceutical company, announced that the U.S. Food and Drug Administration has cleared an investigational new drug application for Comanche’s novel, siRNA therapy to treat preeclampsia.
Bioretec Ltd. has received market authorization for its RemeOs™ trauma screw in the U.S. The RemeOs™ trauma screw is the first and currently only bioresorbable metal implant approved by the U.S. Food and Drug Administration.
Sensorion a pioneering clinical-stage biotechnology company which specializes in gene therapies in the inner ear, announces that its Annual Financial Report for the year ending December 31, 2022, is available to the public and filed with the French financial market authority.
Sensorion Announces the Publication of Its 2022 Annual Financial Report Read More »
Lytix Biopharma AS announces that it has published its Annual Report for 2022, which was approved by the board of directors on March 29, 2023.
